NIBEC Co. Ltd (138610) - Total Assets
Based on the latest financial reports, NIBEC Co. Ltd (138610) holds total assets worth ₩63.61 Billion KRW (≈ $43.10 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 138610 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
NIBEC Co. Ltd - Total Assets Trend (2014–2025)
This chart illustrates how NIBEC Co. Ltd's total assets have evolved over time, based on quarterly financial data. Explore NIBEC Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
NIBEC Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
NIBEC Co. Ltd's total assets of ₩63.61 Billion consist of 59.3% current assets and 40.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 35.0% |
| Accounts Receivable | ₩7.37 Billion | 11.7% |
| Inventory | ₩5.45 Billion | 8.7% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩10.74 Billion | 17.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how NIBEC Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 138610 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NIBEC Co. Ltd's current assets represent 59.3% of total assets in 2025, an increase from 21.7% in 2014.
- Cash Position: Cash and equivalents constituted 35.0% of total assets in 2025, up from 8.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 4.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 17.0% of total assets.
NIBEC Co. Ltd Competitors by Total Assets
Key competitors of NIBEC Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $763.95 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
China | CN¥4.48 Billion |
|
Novavax Inc
NASDAQ:NVAX
|
USA | $1.04 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
NIBEC Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.35 | 1.49 | 5.35 |
| Quick Ratio | 2.81 | 1.23 | 4.74 |
| Cash Ratio | 0.00 | 0.00 | 3.52 |
| Working Capital | ₩26.56 Billion | ₩10.75 Billion | ₩25.70 Billion |
NIBEC Co. Ltd - Advanced Valuation Insights
This section examines the relationship between NIBEC Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.69 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | ₩63.00 Billion |
| Market Capitalization | $141.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values NIBEC Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: NIBEC Co. Ltd's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for NIBEC Co. Ltd (2014–2025)
The table below shows the annual total assets of NIBEC Co. Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩63.00 Billion ≈ $42.70 Million |
+0.88% |
| 2024-12-31 | ₩62.45 Billion ≈ $42.32 Million |
-6.51% |
| 2023-12-31 | ₩66.80 Billion ≈ $45.27 Million |
-11.17% |
| 2022-12-31 | ₩75.20 Billion ≈ $50.96 Million |
+41.16% |
| 2021-12-31 | ₩53.28 Billion ≈ $36.11 Million |
+0.37% |
| 2020-12-31 | ₩53.08 Billion ≈ $35.97 Million |
+48.54% |
| 2019-12-31 | ₩35.73 Billion ≈ $24.22 Million |
+60.12% |
| 2018-12-31 | ₩22.32 Billion ≈ $15.12 Million |
-13.33% |
| 2017-12-31 | ₩25.75 Billion ≈ $17.45 Million |
+12.11% |
| 2016-12-31 | ₩22.97 Billion ≈ $15.57 Million |
+18.22% |
| 2015-12-31 | ₩19.43 Billion ≈ $13.17 Million |
+37.32% |
| 2014-12-31 | ₩14.15 Billion ≈ $9.59 Million |
-- |
About NIBEC Co. Ltd
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more